Workflow
ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics Collaboration
METXBTC Digital(METX) Newsfile·2024-09-18 13:00
          ME Therapeutics Announces the Start of Testing of First mRNA Formulations from NanoVation Therapeutics CollaborationSeptember 18, 2024 9:00 AM EDT | Source: ME Therapeutics Holdings Inc.Vancouver, British Columbia--(Newsfile Corp. - September 18, 2024) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of immuno-oncology, is pleased to announce the start of ef ...